Articles

GLP‑1 medications offer health benefits but their appetite‑suppressing effects can also put you at risk for protein, vitamin, and mineral deficiencies if nutrition is not carefully managed. 

Why GLP‑1 Users Are at Higher Risk for Deficiencies:

GLP‑1 receptor agonists reduce hunger, slow stomach emptying, and often lead to dramatically smaller portions and fewer meals per day. While this supports weight loss, it also means:

-Lower total calorie intake, which can make it difficult to meet daily needs for protein, vitamins, and minerals.

-Reduced variety in the diet due to nausea, early fullness, or changes in taste, which can narrow your nutrient intake even further.

-Faster weight loss, which is linked to greater risk of losing lean muscle along with fat if protein and resistance exercise are not prioritized.

Emerging research shows nutritional deficiencies were diagnosed in over 22% of patients within 12 months of starting a GLP‑1 medication.

The Critical Role of Protein and Muscle Protection:

Muscle is your metabolic “engine,” supporting strength, mobility, blood sugar regulation, and long‑term weight maintenance. When food intake drops quickly on GLP‑1 medications, the body may break down both fat and muscle for energy, especially if daily protein intake is too low.

Key research‑based points:

-General protein recommendations for adults start at about 0.8 g per kg of body weight per day, but higher intakes (around 1.2–1.6 g/kg/day) are often recommended during active weight loss to preserve lean mass.

-Studies in GLP‑1 users suggest that many patients are below optimal protein targets, despite protein making up roughly 18–20% of calories.

-Combining adequate protein with resistance training is strongly recommended to help maintain muscle and bone while on GLP‑1 therapy.

In our work with GLP‑1 clients, we calculate individualized protein targets based on your weight, age, activity level, and health conditions, then translate those numbers into realistic meal and snack ideas you can actually tolerate with reduced appetite.

Key Nutrients to Watch While on GLP‑1’s:

Because GLP‑1 medications do not cause malabsorption, most nutrition risks come from low intake and limited variety rather than from the medication blocking absorption directly. Current research highlights several nutrients that are commonly low in GLP‑1 users:

-Protein – essential for muscle maintenance, immune function, and recovery.

-Vitamin D – frequently deficient; important for bone health, immunity, and mood.

-Calcium – supports bone health, particularly important during rapid weight loss.

-Iron – needed for energy, concentration, and oxygen transport; deficiency can cause fatigue and hair shedding.

-Vitamin B12 – important for nerve function and red blood cell production.

-Magnesium, potassium, and choline – commonly below recommended intakes in GLP‑1 users, important for muscle, heart, and liver function.

We at Fit4Life Nutrition can help interpret nutrition lab results, medical history, and diet patterns to identify which of these nutrients are most concerning for you and build a plan that may include food‑first strategies, targeted supplementation when appropriate, and follow‑up labs in collaboration with your medical team. We are currently accepting new clients. 

Disclaimer: The content provided is for educational purposes and not intended for medical use. We may have used AI-assisted tools for our content, all information has been reviewed by Fit4Life Nutrition to ensure it is accurate, evidence based, and aligned with your health needs.

References:

Nutritional priorities to support GLP‑1 therapy for obesity. Nutrients. 2025;17(12):2456. NCBI/NIH: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12264624

Dietary intake by patients taking GLP‑1 and dual GIP/GLP‑1 receptor agonists: a narrative review and discussion of research needs. NCBI/NIH: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11340591

Dietary intake by patients taking GLP‑1 and dual GIP/GLP‑1 receptor agonists – PubMed record (same study, indexing energy‑intake reductions and macronutrient distribution). PubMed: https://pubmed.ncbi.nlm.nih.gov/39175746

Diet quality and nutrient distribution while using glucagon‑like peptide‑1 receptor agonists (GLP‑1RAs). NCBI/NIH: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12369429

Nutritional priorities to support GLP‑1 therapy for obesity – PubMed record (joint advisory summary; details on protein ranges, lean‑mass preservation, and micronutrient priorities). PubMed: https://pubmed.ncbi.nlm.nih.gov/40445127

Newswise summary of the joint advisory “Nutritional Priorities to Support GLP‑1 Therapy for Obesity” (emphasizes adequate protein, resistance exercise, and preventing micronutrient deficiencies). https://www.newswise.com/articles/nutritional-priorities-to-support-glp-1-therapy-for-obesity

NIH Office of Dietary Supplements – Vitamin and Mineral Supplement Fact Sheets (used for vitamin D, calcium, iron, vitamin B12, magnesium, potassium, and choline roles and deficiency risks). https://ods.od.nih.gov/factsheets/list-VitaminsMinerals